Anti-Siglec-2 / CD22 (NCI m972)
Anti-Siglec-2 / CD22 (NCI m972) is a humanized monoclonal antibody targeting CD22, a Siglec family lectin present on B cells. It is a promising novel therapeutics for B-cell acute lymphoblastic leukemia (BCP-ALL). MW :144.3 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3058 |
Sku # | A3058-1mg |
Pricing | 1mg, $539.00 |